Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Retained Earnings (2014 - 2026)

Cellectis (CLLS) posted quarterly Retained Earnings of -$334.2 million for Q1 2026, down 1.4% year-over-year from -$338.9 million in Q1 2025, and down 25.38% quarter-over-quarter from -$266.5 million in Q4 2025.

Analysis

Cellectis (CLLS) Retained Earnings (2014 - 2026) Analysis & Trends

Cellectis' Retained Earnings history runs 13 years deep, the most recent figure standing at -$334.2 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 1.4% year-over-year to -$334.2 million; the TTM figure through Mar 2026 stood at -$334.2 million (down 1.4% YoY), while the FY2025 annual figure was -$266.5 million, up 8.98% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$334.2 million, down from -$266.5 million in the prior quarter.
  • The five-year high for Retained Earnings was -$266.5 million in Q4 2025, with the low at -$696.1 million in Q1 2022.
  • The 5-year median for Retained Earnings is -$329.6 million (2025), against an average of -$353.5 million.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings surged 45.28% in 2022, then plunged 33.05% in 2024.
  • Cellectis' Retained Earnings stood at -$333.4 million in 2022, then grew by 8.6% to -$304.7 million in 2023, then climbed by 3.89% to -$292.8 million in 2024, then grew by 8.98% to -$266.5 million in 2025, then declined by 25.38% to -$334.2 million in 2026.
  • Business Quant data shows CLLS's Retained Earnings at -$334.2 million in Q1 2026, -$266.5 million in Q4 2025, and -$266.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Cellectis 321.90 Mn 155.05 Mn - -264.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -264.34 Mn
Mar 31, 2026 -334.17 Mn
Dec 31, 2025 -266.54 Mn
Sep 30, 2025 -266.59 Mn
Jun 30, 2025 -266.59 Mn
Mar 31, 2025 -329.56 Mn
Dec 31, 2024 -292.85 Mn
Sep 30, 2024 -405.80 Mn
Jun 30, 2024 -405.73 Mn
Mar 31, 2024 -405.81 Mn
Dec 31, 2023 -304.71 Mn
Sep 30, 2023 -304.99 Mn
Jun 30, 2023 -305.39 Mn
Mar 31, 2023 -439.22 Mn
Dec 31, 2022 -333.37 Mn
Sep 30, 2022 -330.60 Mn
Jun 30, 2022 -320.81 Mn
Mar 31, 2022 -696.06 Mn
Dec 31, 2021 -584.13 Mn
Sep 30, 2021 -586.72 Mn